Mechanisms of Disease: HCV-induced liver injury
- 1 November 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Gastroenterology & Hepatology
- Vol. 4 (11), 622-634
- https://doi.org/10.1038/ncpgasthep0961
Abstract
HCV persistently infects the majority of patients exposed to it and can cause irreversible fibrosis, leading to the onerous clinical sequelae of cirrhosis. In this Review, we discuss the direct effects of HCV on hepatocytes and the role of the immune system in liver damage. HCV, like many viruses, has developed methods by which to subvert host innate and adaptive immune responses to infection. HCV proteins seem to modulate apoptosis and steatosis, ultimately leading to hepatic stellate cell activation, fibrosis and hepatocellular carcinoma. In addition, HCV manipulates the immune system, disrupting both innate and adaptive immunity to establish persistent infection. The immune system initially attempts to eradicate the virus, but, in the setting of chronic infection, probably promotes hepatocyte damage and fibrosis through direct cellular toxicity and the release of inflammatory cytokines. Multiple types of cytotoxic lymphocytes, comprising the unique immune hepatic microenvironment, are likely to be important in the pathogenesis of HCV-induced liver damage. The net liver damage from HCV infection depends on the balance between the host's antiviral mechanisms and the virus' ability to subvert them.Keywords
This publication has 91 references indexed in Scilit:
- Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative StressJournal of Virology, 2007
- Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory ProteinJournal of Virology, 2006
- Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman SymposiumHepatology, 2006
- Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCJournal of Hepatology, 2006
- Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intakeGut, 2005
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate CellsJournal of Biological Chemistry, 2005
- Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infectionJournal of Hepatology, 2002
- Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis CDigestive Diseases and Sciences, 1996